Teva Receives FDA Action Letter For Generic Lovenox®
Jan. 25, 2011: JERUSALEM–(BUSINESS WIRE)–Teva Pharmaceutical Industries Ltd. (NASDAQ: TEVA) announced today that it has received correspondence from the U.S. Food and Drug Administration (FDA) regarding the Company’s abbreviated new drug application (ANDA) for generic Lovenox® (enoxaparin sodium) injection. The receipt of this action letter, called a Minor Deficiency letter, indicates that the FDA has […]
Read More »Category : News
Federal Government to Assist Pharmaceutical Developments
Jan. 25, 2011: National Institutes of Health has approved Obama’s decision to assist with funding for drug research and development through a Federal Research Center. The Obama administration has decided to go forward with a decision to develop a drug development center. The announcement, initially made in December 2010, revealed that the administration was considering such […]
Read More »Category : News
Angiotech Pharmaceuticals Inc., unable to regain compliance with NASDAQ listing standards, is delisted from the exchange
Angiotech Pharmaceuticals Inc., unable to regain compliance with NASDAQ listing standards, is delisted from the exchange Jan. 26, 2011: Angiotech Pharmaceuticals Inc.’s (OTC:ANPI) shares are no longer traded on NASDAQ as of today. The Vancouver-based company failed to regain compliance with the stock exchange’s listing rules within a 180-day period that ended Jan. 3. NASDAQ […]
Read More »Category : News
